Roshni Kulkarni/LinkedIn
Nov 12, 2026, 09:30
Roshni Kulkarni: A New Hope for Preventing Recurrent Stroke
Roshni Kulkarni, Professor at Michigan State University, shared a post on LinkedIn:
“As a stroke survivor I am eagerly awaiting approval and availability of this drug that may prevent recurrence.
Stroke changed my life but I am not ready to give up.
Kudos to Bayer!”
Stay updated with Hemostasis Today.
-
Nov 12, 2026, 09:50Denis Oduor: Did You Know What Happens to Your Body After You Donate Blood?
-
Nov 12, 2026, 09:49Care Beyond Borders for Women With Bleeding Disorders – EHC
-
Nov 12, 2026, 09:35Factor XIa Inhibition Enters Clinical Practice With First FDA Approval
-
Nov 12, 2026, 09:17Gashaw Arega Mekonnen: Jimma Moments – A Shared Mission for Childhood Cancer Care
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?